2024 Flinn Foundation Translational Research Seed Grant Program

Institutionally Coordinated // PIs: 
R. Goyal (Obstetrics and Gynecology)
A. Gallitano (Research Series - Basic Medical Sciences)
M. Cai (Chemistry and Biochemistry)
I.Gladysheva (Research Series - Internal Medicine)
G.Gurtner (Surgery)
S.Goldman (Cardiology)
Z.Li (Orthopaedic Research)
P. Govindappa (Orthopaedic Surgery)
M. Ahmed (Neonatology)
A. Avellino (Pediatric Neurosurgery)
C. Curiel-Lewandrowski (Dermatology)
E. Erickson (Nursing)/ S. Aras (Sensor Analysis & Smart Platforms)
H.Li (Pharmacology and Toxicology)
M. Johnson (Immunobiology)
J. Lacombe (Research Series - Basic Medical Sciences)
R. Liang (Optical Sciences)
E. Enikov (Aerospace and Mechanical Engineering)
C.Hulme (Chemistry and Biochemistry)

Submissions will require an institutional letter of support. Because of this support requirement, this is an Institutionally Coordinated Submission. 

The Flinn Foundation’s 2023 Seed Grants to Promote Translational Research Program will fund up to 10 research teams focused on advancing new products or services to improve patient care. The teams must be affiliated with Arizona’s academic research institutions and/or health-care systems.

The awardees will each receive a $100,000 grant over 18 months. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.

The proposed projects must address compelling clinical needs in the areas of precision medicine, diagnostics, devices, therapeutics, or health-care-delivery processes and have significant potential to turn bench results into viable products or systems impacting patients in Arizona and beyond.